Unternehmensübersicht
National Health Investors, Inc. operates as a self-managed real estate investment trust that specializes in sale-leaseback transactions, joint ventures, and mortgage or mezzanine financing focused on need-driven and discretionary senior housing and medical facility investments. The company functions within the Real Estate sector, specifically categorized under the REIT - Healthcare Facilities industry, which implies a business model heavily reliant on property ownership and healthcare-related lease agreements. At its current scale, the entity manages a market capitalization of $3.98 billion while generating trailing twelve-month revenue of $379.29 million with a workforce of 32 employees. These valuation metrics and revenue figures indicate that the company holds a substantial position in the healthcare real estate market, supported by a significant balance sheet despite a lean operational staff size.
Finanzielle Gesundheit
The company reported a revenue of $379.29 million over the trailing twelve months, resulting in a net income of $141.98 million and an EBITDA of $276.77 million. The substantial gap between the revenue figure and the net income reveals a highly efficient cost structure where operating expenses and taxes consume only a fraction of total sales, contributing to a profit margin of 37.5%. Free cash flow stands at $195.47 million, indicating strong financial flexibility that allows the entity to service its obligations or pursue strategic opportunities without immediate reliance on external financing. The gross margin is 81.0%, while the operating margin reaches 62.6%, figures that demonstrate the company's ability to retain significant value from its core real estate operations before interest and taxes. Regarding liquidity and leverage, the company holds cash of $32.54 million against total debt of $1.43 billion, resulting in a debt-to-equity ratio of 92.14%, which characterizes a highly leveraged balance sheet typical for REIT structures. The current ratio is recorded at 0.54, suggesting that current assets do not cover current liabilities, a standard condition for capital-intensive real estate firms but requiring careful monitoring of cash flow generation. Return on equity is 9.6% and return on assets is 4.5%, metrics that reveal the efficiency with which management utilizes shareholder capital and total assets to generate profits within a leveraged environment.
Bewertungsanalyse
The trailing twelve-month P/E ratio is 27.22, whereas the forward P/E is projected at 22.58, implying that the market expects earnings growth or a multiple contraction in the near future to justify the current price. The price-to-book ratio stands at 2.44, indicating that the stock trades at a significant premium over its book value, reflecting the market's valuation of its asset quality and brand. Alternative valuation metrics such as the price-to-sales ratio of 10.50 and an EV/EBITDA of 18.72 provide further context, suggesting the market prices the stock based on revenue generation and cash-flow-adjusted earnings rather than traditional multiples alone. The 52-week high was $91.38 and the low was $66.41; depending on the current market price, the stock sits within this historical trading range, reflecting recent volatility or consolidation. The beta value of 0.66 indicates that the stock exhibits lower price volatility relative to the broader market, suggesting it may move less drastically than the overall index during periods of market stress.
Growth & Income
Revenue growth year-over-year is -11.7% and earnings growth year-over-year is -14.1%, indicating that earnings are currently shrinking at a slightly faster rate than revenue, which can be attributed to the leverage effects or cost adjustments inherent in the real estate sector. As a dividend payer, the company offers a dividend yield of 4.5% with a payout ratio of 120.5%, a figure that suggests the dividend is funded from cash flows and non-cash items rather than current earnings, raising questions about sustainability if earnings do not improve. Given the payout ratio exceeding 100%, the company effectively reinvests minimal earnings into growth while maintaining high shareholder distributions, a strategy common in mature REITs with stable cash flows. The overall growth and income profile presents a trade-off between high current income yield and negative growth rates, requiring investors to weigh the stability of the healthcare asset base against the recent contraction in financial performance metrics.
Vergleich mit Mitbewerbern
National Health Investors, Inc. (NHI) ist in der REIT - Gesundheitseinrichtungen-Branche tätig. So schneidet das Unternehmen im Vergleich zu seinen nächsten Mitbewerbern nach Marktkapitalisierung ab:
Das durchschnittliche KGV der REIT - Gesundheitseinrichtungen-Branche beträgt 60.2x. National Health Investors, Inc. wird mit einem KGV von 24.6 gehandelt.